What is the optimal length of stay in hospital for ST elevation myocardial infarction treated with primary percutaneous coronary intervention?

Cardiology Journal

Volumn 18, Issue 4, 2011, Pages 378-384

  Karabulut, Ahmet ^a   Cakmak, Mahmut ^a   Uzunlar, Bulent ^a   Bilici, Ahmet ^b  

^a Istanbul Medicine Hospital   (Turkey)

^b DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Early discharge; Myocardial infarction; Primary intervention

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT DISCHARGE; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 79960613611     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jirmar R, Widimsky P, Capek J, Hinomaz O, Goch L. Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Pra-gue-5". Int Heart J, 2008; 49: 653-659.
2. Kotowycz MA, Syal RP, Afzal R, Natarajan MK. Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutanous coronary intervention? Can J Cardiol, 2009; 25: 585-588.
3. Yip HK, Wu CJ, Chang HW et al. The feasibility and safety of early discharge for low risk patients with acute myocardial infarction after successful direct percutanous coronary intervention. Jpn Heart J, 2003; 44: 41-49.
4. Kotowycz MA, Cosman TL, Tartaglia C, Afzal R, Syal RP, Natarajan MK. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction: A prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). Am Heart J, 2010; 159: 117.e1-117.e6.
5. Grines CL, Marsalese DL, Brodie B et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol, 1998; 31: 967-72.
6. Bajraktari G, Thaqi K, Pacolli S et al. In-hospital mortality following acute myocardial infarction in Kosovo: A single center study. Ann Saudi Med, 2008; 28: 430-434.
7. Weaver WD, Simes RJ, Betriu A et al. Comparision of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA, 1997; 278: 2093-2098.
8. Grygier M, Araszkiewicz A, Lesiak M, Grajek S. Acute myocar-dial infarction in an 80 year-old woman caused by left main occlusion with concomitant chronic total occlusions of right and left coronary artery: Successful treatment with percutaneous revascularization. Cardiol J, 2009; 16: 568-572.
9. Schaer BA, Osswald S, Zellweger MJ, Jegge S, Sticherling C, Pfisterer M. Impact of contemporary emergency percutanous coronary angioplasty for acute myocardial infarction on length of hospital stay. Swiss Med Wkly, 2007; 137: 363-367.
10. Bramkamp M, Radovanovic D, Erne P, Szucs TD. Determinants of cost and the length of stay in acute coronary syndromes: A real life analysis of more than 10,000 patients. Cardiovasc Drugs Ther, 2007; 21: 389-398.
11. Heggunje PS, Harjai KJ, Stone GW et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol, 2004; 44: 1400-1407.
12. Branca G, Capodanno D, Capranzano P et al. Early discharge in acute myocardial infarction after clinical and angiographic risk assessment. J Cardiovasc Med (Hagerstown), 2008; 9: 858-861.